05:25 AM EDT, 04/03/2024 (MT Newswires) -- (Updates with the stock move in the headline and the last paragraph.)

Sight Sciences ( SGHT ) said late Tuesday that results from studies of two of its glaucoma and dry eye technologies will be presented at this year's meeting of the American Society of Cataract and Refractive Surgery, which will take place from April 5 to April 8 in Boston.

The results showed the "long-term efficacy of the OMNI Surgical System for primary open-angle glaucoma" and back the use of TearCare as "a primary treatment for dry eye disease," the company said.

Sight Sciences ( SGHT ) shares touched gains of 25% in after-hours activity on Tuesday and traded over 12% higher in the premarket on Wednesday.

Price: 6.10, Change: +0.66, Percent Change: +12.13